HOPITAUX UNIVERSITAIRES DE GENEVE
5Patents
5Active
5Granted
44Portfolio score
Filing activity: Nov 20, 2008 → Jan 27, 2017 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9599624B2 | BARD1 isoforms in lung and colorectal cancer and use thereof | Physics | 6 | Active |
| US9187534B2 | Multi-epitopic vaccine | Emerging Cross-Sectional Technologies | 5 | Active |
| US8614095B2 | Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US8815844B2 | Mitochondrial activity inhibitors of cancer-initiating cells and use thereof | Physics | 2 | Active |
| US11022612B2 | BARD1 isoforms in lung and colorectal cancer and use thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.